Clinical Trials on Sebaceous Hyperplasia

Total 2206 results

Chinese University of Hong Kong

Completed

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

Benign Prostate Hyperplasia

Hong Kong
MedeonBio, Inc.

Active, not recruiting

Safety and Feasibility of the XFLO Expander System (Mercury) (EXPANDER-1)

Benign Prostatic Hyperplasia

Taiwan, Canada, Australia, Georgia
Academisch Medisch Centrum - Universiteit van Amsterdam...
Elesta S.R.L.

Completed

Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction

Prostatic Hyperplasia, Benign

Netherlands
Fudan University

Terminated

Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia

Atypical Endometrial Hyperplasia

China
Vanderbilt University Medical Center

Completed

A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial

Benign Prostatic Hyperplasia

United States
Chinese University of Hong Kong

Terminated

Waterjet Prostate Ablation

Benign Prostatic Hyperplasia

Hong Kong
Mansoura University

Completed

High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH

Benign Prostatic Hyperplasia

Egypt
University of North Carolina, Chapel Hill
BTG International Inc.; Embolx, Inc.

Withdrawn

Ga-68 MAA Distribution in PAE Patients

Benign Prostatic Hyperplasia

United States
University of Kansas Medical Center

Unknown

Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Boston Scientific Corporation

Completed

Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH

Benign Prostatic Hyperplasia

United Kingdom, Germany, Austria, Spain, Belgium, France, Italy, Netherlands, Switzerland
Ain Shams University

Completed

Comparison of Holmium Laser Enucleation Prostatectomy and Open Transvesical Prostatectomy in Large Prostate

Benign Prostatic Hyperplasia

Egypt
Ahmed Maher Gamil Ahmed Higazy

Completed

HoLEP Vs BPEP for Large Prostatic Adenoma (enucleation)

Prostate Hyperplasia

Egypt
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

Benign Prostatic Hyperplasia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

Benign Prostatic Hyperplasia

Korea, Republic of
Germans Trias i Pujol Hospital

Unknown

Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Spain
Samsung Medical Center

Completed

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of
Tampa General Hospital

Unknown

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

Benign Prostatic Hyperplasia

United States
NeoTract, Inc.

Completed

UroLift System TOlerability and ReCovery When Administering Local Anesthesia (LOCAL)

Benign Prostatic Hyperplasia

United States
Materia Medica Holding

Completed

Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

Benign Prostatic Hyperplasia

Russian Federation, Ukraine
Johns Hopkins University

Completed

Ultrasound-Guided Photoselective Vaporization of the Prostate

Benign Prostatic Hyperplasia

United States
Olympus Corporation of the Americas
Loma Linda University; VA Greater Los Angeles Healthcare System

Terminated

Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode

Benign Prostatic Hyperplasia

United States
University of North Carolina, Chapel Hill

Completed

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Mansoura University

Completed

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

Benign Prostate Hyperplasia

Egypt
Yuyu Pharma, Inc.

Completed

A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects

Benign Prostate Hyperplasia
Yonsei University

Completed

Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients

Benign Prostate Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Korea, Republic of
Saskatchewan Health Authority - Regina Area

Completed

Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Benign Prostate Hyperplasia

Canada
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
American Medical Systems

Completed

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization (PVP)

Benign Prostatic Hyperplasia

United States
Medifocus, Inc.

Unknown

Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostate Hyperplasia

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

Benign Prostate Hyperplasia

Korea, Republic of
Bayer

Completed

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Singapore General Hospital

Completed

To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate

Benign Prostatic Hyperplasia

Singapore
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates

Benign Prostate Hyperplasia

China
Eli Lilly and Company

Completed

Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Korea, Republic of, Japan
Seoul National University Hospital
GlaxoSmithKline; The Korean Urological Association

Completed

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

Benign Prostatic Hyperplasia
Eli Lilly and Company

Completed

A Study in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Italy, Austria
Eli Lilly and Company

Completed

A Study of Tadalafil in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Seoul National University Hospital
GlaxoSmithKline; Seoul National University Bundang Hospital

Completed

One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Taipei Medical University WanFang Hospital

Unknown

An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

Benign Prostatic Hyperplasia

Taiwan
Eli Lilly and Company

Completed

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

Benign Prostatic Hyperplasia

Japan
Eli Lilly and Company

Completed

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Benign Prostatic Hyperplasia

Italy, United States, Germany, Mexico, Argentina
Pnn Medical A/S

Completed

Temperature Mapping of the Prostate With the Wallterm™ System (WT-DK-TMW08)

Benign Prostatic Hyperplasia

Denmark
National Institute of Diabetes and Digestive and...
Merck Sharp & Dohme LLC; Medtronic; Sanofi-Synthelabo; Diagnostic Ultrasound; Uro...

Terminated

Minimally Invasive Surgical Therapy for BPH (MIST)

Benign Prostatic Hyperplasia

United States
National Institute of Diabetes and Digestive and...
National Center for Complementary and Integrative Health (NCCIH)

Completed

Saw Palmetto Extract in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Threshold Pharmaceuticals

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Urologic Consultants of Southeastern PA

Unknown

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

Benign Prostatic Hyperplasia

United States

3

Subscribe